SS
TNYA icon

SBI Securities’s Tenaya Therapeutics TNYA Stock Holding History

SBI Securities’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.17K Buy
1,583
+800
+102% +$607 ﹤0.01% 2745
2026
Q1 		$542 Hold
783
– – ﹤0.01% 2866
2025
Q4 		$557 Sell
783
-701
-47% -$953 ﹤0.01% 2833
2025
Q3 		$2.4K Sell
1,484
-99
-6% -$100 ﹤0.01% 2350
2025
Q2 		$968 Hold
1,583
– – ﹤0.01% 2696
2025
Q1 		$902 Hold
1,583
– – ﹤0.01% 2626
2024
Q4 		$2.26K Buy
+1,583
New +$3.55K ﹤0.01% 2259

Other funds holding TNYA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.77B AUM 65.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SBI Securities's TNYA Position: Q2 2026 in Review

SBI Securities increased its Tenaya Therapeutics (TNYA) stake by 102% in Q2 2026, buying an estimated $607 and bringing the position to 1,583 shares worth $1.17K. The position accounts for ﹤0.01% of the portfolio, ranked #2745.

SBI Securities first reported a position in TNYA in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.4K in Q3 2025. 101 funds tracked by Wall St. Rank hold TNYA as of Q2 2026.

  • SBI Securities held 1,583 shares of Tenaya Therapeutics worth $1.17K as of Q2 2026.
  • SBI Securities bought 800 Tenaya Therapeutics shares in Q2 2026, an estimated $607.
  • Tenaya Therapeutics made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #2745 holding.
  • SBI Securities first reported a position in Tenaya Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Tenaya Therapeutics position peaked at $2.4K in Q3 2025.
  • 101 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.